9 research outputs found
Regional and cellular gene expression changes in human Huntington's disease brain
Huntington's disease (HD) pathology is well understood at a histological level but a comprehensive molecular analysis of the effect of the disease in the human brain has not previously been available. To elucidate the molecular phenotype of HD on a genome-wide scale, we compared mRNA profiles from 44 human HD brains with those from 36 unaffected controls using microarray analysis. Four brain regions were analyzed: caudate nucleus, cerebellum, prefrontal association cortex [Brodmann's area 9 (BA9)] and motor cortex [Brodmann's area 4 (BA4)]. The greatest number and magnitude of differentially expressed mRNAs were detected in the caudate nucleus, followed by motor cortex, then cerebellum. Thus, the molecular phenotype of HD generally parallels established neuropathology. Surprisingly, no mRNA changes were detected in prefrontal association cortex, thereby revealing subtleties of pathology not previously disclosed by histological methods. To establish that the observed changes were not simply the result of cell loss, we examined mRNA levels in laser-capture microdissected neurons from Grade 1 HD caudate compared to control. These analyses confirmed changes in expression seen in tissue homogenates; we thus conclude that mRNA changes are not attributable to cell loss alone. These data from bona fide HD brains comprise an important reference for hypotheses related to HD and other neurodegenerative disease
Transcriptional dysregulation in Huntington's disease
Huntington’s disease (HD) is an autosomal dominant neurodegeneration which is associated with an expanded CAG repeat in a large gene on chromosome 4p. The protein product of the gene, huntingtin, thus contains an expanded glutamine tract close to its N-terminus. Although the genetic lesion was defined in 1993 (Huntington’s disease collaborative research group, 1993) neither the normal nor pathological function of huntingtin has been defined. Despite the widespread expression of the HD gene in effectively all cell types examined (DiFiglia et al., 1995; Ferrante et al., 1997; Gutekunst et al., 1995; Kosinski et al., 1997) the initial pathology of HD is restricted and specific populations of neurons in the striatum are vulnerable (Vonsattel et al., 1985). The neurons which die first are the medium spiny projection neurons in the caudate and putamen, and those most vulnerable are the enkephalin-containing, dopamine D2 expressing neurons projecting to the globus pallidus pars externa (GPe) (Albin et al., 1990; 1992). The death of neurons is accompanied by extensive reactive gliosis and, at later stages of disease, atrophy occurs in other regions of the basal ganglia and elsewhere with brain weight at death significantly reduced compared to controls (Vonsattel et al., 1985)
Supporting Children’s Social Connection and Well-Being in School-Age Care:Mixed Methods Evaluation of the Connect, Promote, and Protect Program
Regional and cellular gene expression changes in human Huntington's disease brain
Huntington's disease (HD) pathology is well understood at a histological level but a comprehensive molecular analysis of the effect of the disease in the human brain has not previously been available. To elucidate the molecular phenotype of HD on a genome-wide scale, we compared mRNA profiles from 44 human HD brains with those from 36 unaffected controls using microarray analysis. Four brain regions were analyzed: caudate nucleus, cerebellum, prefrontal association cortex [Brodmann's area 9 (BA9)] and motor cortex [Brodmann's area 4 (BA4)]. The greatest number and magnitude of differentially expressed mRNAs were detected in the caudate nucleus, followed by motor cortex, then cerebellum. Thus, the molecular phenotype of HD generally parallels established neuropathology. Surprisingly, no mRNA changes were detected in prefrontal association cortex, thereby revealing subtleties of pathology not previously disclosed by histological methods. To establish that the observed changes were not simply the result of cell loss, we examined mRNA levels in laser-capture microdissected neurons from Grade 1 HD caudate compared to control. These analyses confirmed changes in expression seen in tissue homogenates; we thus conclude that mRNA changes are not attributable to cell loss alone. These data from bona fide HD brains comprise an important reference for hypotheses related to HD and other neurodegenerative diseases
Regional and cellular gene expression changes in human Huntington's disease brain
Huntington's disease (HD) pathology is well understood at a histological level but a comprehensive molecular analysis of the effect of the disease in the human brain has not previously been available. To elucidate the molecular phenotype of HD on a genome-wide scale, we compared mRNA profiles from 44 human HD brains with those from 36 unaffected controls using microarray analysis. Four brain regions were analyzed: caudate nucleus, cerebellum, prefrontal association cortex [Brodmann's area 9 (BA9)] and motor cortex [Brodmann's area 4 (BA4)]. The greatest number and magnitude of differentially expressed mRNAs were detected in the caudate nucleus, followed by motor cortex, then cerebellum. Thus, the molecular phenotype of HD generally parallels established neuropathology. Surprisingly, no mRNA changes were detected in prefrontal association cortex, thereby revealing subtleties of pathology not previously disclosed by histological methods. To establish that the observed changes were not simply the result of cell loss, we examined mRNA levels in laser-capture microdissected neurons from Grade 1 HD caudate compared to control. These analyses confirmed changes in expression seen in tissue homogenates; we thus conclude that mRNA changes are not attributable to cell loss alone. These data from bona fide HD brains comprise an important reference for hypotheses related to HD and other neurodegenerative diseases